X
XWELL Inc. (XWEL)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
$0.53
-0.03 (-5.42%)
Market Cap: $5.62M
Last updated: Nov 17, 2026 at 11:02 AM ET
XWELL Inc. (XWEL) Valuation Multiples
XWELL (XWEL) trades at 0.2x sales. Its P/S of 0.2x is in line with its 5-year median. Its forward P/E is 10.8x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 10.8x |
| Price to sales | 0.2x |
| EV/FCF | 0.5x |
| PEG | N/A |
| FCF yield | -300.3% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 0.2x | 0.2x | N/A |
Valuation History
Over the 5 of the 8 year ends shown that have a P/S, its P/S ranged from 0.1x in 2018 to 2.9x in 2021.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $0.46 | N/A | N/A |
| 2024 | $1.51 | 0.2x | N/A |
| 2023 | $1.74 | 0.2x | 0.6x |
| 2022 | $7.26 | 0.6x | 0.8x |
| 2021 | $40.40 | 2.9x | 2.3x |
| 2020 | $23.80 | N/A | 28.8x |
| 2019 | $40.20 | N/A | 6.4x |
| 2018 | $187.22 | 0.1x | 0.4x |
Frequently Asked Questions About XWEL
What is XWEL's forward P/E ratio?
XWELL has a forward P/E ratio of 10.8x.
What is XWEL's price to sales ratio?
XWELL has a price to sales ratio of 0.2x.
XWEL pages: Overview, Earnings, Financials, Valuation, Competitors, Government Contracts